Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (631-640 of 738) with videos related to

Pageof 74
Sort By:
Internal Medicine Journal|January 5, 2011
Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation ProgramP A McCullough, A Whaley-Connell, W W Brown, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practiceGeorge Bakris, Michael Böhm, Gilles Dagenais, et al.
Diabetes, Obesity & Metabolism|July 4, 2023
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY studyPeter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
beta-blocker use and diabetes symptom score: results from the GEMINI studyJ B McGill, G L Bakris, V Fonseca, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2018
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney FoundationRichard J Johnson, George L Bakris, Claudio Borghi, et al.
JAMA|September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical TrialGeorge L Bakris, Rajiv Agarwal, Juliana C Chan, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trialSimon R Heller, Richard M Bergenstal, William B White, et al.
Journal of the National Cancer Institute|March 31, 2010
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitorsMichael L Maitland, George L Bakris, Henry R Black, et al.
Pageof 74

Showing results (631-640 of 738) with videos related to

Sort By:
Pageof 74
Internal Medicine Journal|January 5, 2011
Cardiovascular risk modification in participants with coronary disease screened by the Kidney Early Evaluation ProgramP A McCullough, A Whaley-Connell, W W Brown, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 30, 2008
Cardiovascular protection for all individuals at high risk: evidence-based best practiceGeorge Bakris, Michael Böhm, Gilles Dagenais, et al.
Diabetes, Obesity & Metabolism|July 4, 2023
The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY studyPeter Rossing, Stefan D Anker, Gerasimos Filippatos, et al.
Diabetes, Obesity & Metabolism|March 30, 2007
beta-blocker use and diabetes symptom score: results from the GEMINI studyJ B McGill, G L Bakris, V Fonseca, et al.
JAMA|September 4, 2013
Effect of aliskiren on progression of coronary disease in patients with prehypertension: the AQUARIUS randomized clinical trialStephen J Nicholls, George L Bakris, John J P Kastelein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2018
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney FoundationRichard J Johnson, George L Bakris, Claudio Borghi, et al.
JAMA|September 2, 2015
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical TrialGeorge L Bakris, Rajiv Agarwal, Juliana C Chan, et al.
Diabetes Care|June 12, 2016
Cardiovascular Mortality in Patients With Type 2 Diabetes and Recent Acute Coronary Syndromes From the EXAMINE TrialWilliam B White, Stuart Kupfer, Faiez Zannad, et al.
Diabetes, Obesity & Metabolism|January 7, 2017
Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trialSimon R Heller, Richard M Bergenstal, William B White, et al.
Journal of the National Cancer Institute|March 31, 2010
Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitorsMichael L Maitland, George L Bakris, Henry R Black, et al.
Pageof 74